Product
DYNE-251
1 clinical trial
1 indication
Indication
Duchenne Muscular DystrophyClinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study Assessing Safety, Tolerability, Pharmacodynamics, Efficacy, and Pharmacokinetics of DYNE-251 Administered to Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 SkippingStatus: Recruiting, Estimated PCD: 2026-11-01